Christoph Eimer

Lukaskrankenhaus — Germany

Medicine · Health Sciences

10h-index239citations24works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(7), Hernia repair and management(5), Urological Disorders and Treatments(5), Pelvic floor disorders treatments(4), Bladder and Urothelial Cancer Treatments(4)

Publications24 total

Inflammatory Reaction as Determinant of Foreign Body Reaction Is an Early and Susceptible Event after Mesh Implantation
BioMed Research International·2014· 34 citedOpen Access
Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy
Anti-Cancer Drugs·2013· 31 cited
IDEAL in Meshes for Prolapse, Urinary Incontinence, and Hernia Repair
Surgical Innovation·2013· 37 cited
Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts<i>In Vitro</i>: Development Stage of a Surgical Innovation
BioMed Research International·2013· 18 citedOpen Access
Early Endoscopic Detection and Subsequent Removal of Sphincter Penetrating Anastomotic Sutures May Prevent Irreversible Urinary Incontinence After Radical Prostatectomy
Journal of Endourology·2012· 3 cited
Temsirolimus in platinum-resistant metastatic urothelial cancer: A phase II trial.
Journal of Clinical Oncology·2012· 1 cited
Autologous plasma coating leading to improved biocompatibility of meshes used for hernia, incontinence and organ prolapse repair – results of in-vitro and in-vivo studies
Neurourology and Urodynamics·2012
Evaluation of Biocompatibility of Alloplastic Materials: Development of a Tissue Culture In Vitro Test System.
PubMed·2011· 12 cited
Sphincter Lesions After Radical Prostatectomy—Evaluation and Classification
Journal of Endourology·2011· 15 cited
mTOR inhibition in advanced renal cell carcinoma
Anti-Cancer Drugs·2010· 2 cited
Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma
Anti-Cancer Drugs·2010· 12 cited
Reply
Urology·2010
Reply
Urology·2010
1523 THERAPY OF REFRACTORY POSTOPERATIVE URINARY STRESS INCONTINENCE BY THE USE OF AUTOLOGOUS SKELETAL MUSCLE-DERIVED CELLS (MDC)
The Journal of Urology·2010
1599 PREVENTION OF URINARY STRESS INCONTINENCE CAUSED BY RADICAL RETROPUBIC PROSTATECTOMY (RRP) BY EARLY ENDOSCOPIC REMOVAL OF THE ANASTOMOSIS SUTURES
The Journal of Urology·2010
Nephrocutaneous Bypass in Ureteral Obstruction
Urology·2010· 15 cited
Therapy of refractory postoperative urinary stress incontinence by the use of autologous skeletal muscle- derived cells (MDC)
Neurourology and Urodynamics·2010· 1 cited
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma
Medical Oncology·2009· 31 cited
„Targeted therapy“ des metastasierten Nierenzellkarzinoms (mRCC)
Onkopipeline·2008
Synchronous Arterioureteral, Ureterocolic and Arteriocolic Fistula in a Patient with Metastasised Carcinoid Tumor - An Upcoming Problem for Long-Term Survivors of Anticancer Therapy
Current Urology·2008· 3 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Holger Gerullis(24), Thomas Otto(18), Evangelos Georgas(7), Thorsten Ecke(6), J. Bagner(6), T. Otto(6), B. Klosterhalfen(5), Mihály Boros(5), Klaus Schwartmann(5), Albert Ramon(4), Christoph Heuck(4), Bernhard J. Lammers(3), Christian Arndt(3), Sonja Quast(3), Sunil Kocheril(3), Peter E. Goretzki(3), Dimitri Barski(2), Lothar Bergmann(2), Luise Maute(2), Mohamed Wishahi(2)